These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23992752)

  • 1. Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury.
    Rao Y; Zhu W; Guo Y; Jia C; Qi R; Qiao R; Cao D; Zhang H; Cui Z; Yang L; Wang Y
    Cell Transplant; 2013; 22 Suppl 1():S21-5. PubMed ID: 23992752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.
    Huang H; Xi H; Chen L; Zhang F; Liu Y
    Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.
    Tabakow P; Jarmundowicz W; Czapiga B; Fortuna W; Miedzybrodzki R; Czyz M; Huber J; Szarek D; Okurowski S; Szewczyk P; Gorski A; Raisman G
    Cell Transplant; 2013; 22(9):1591-612. PubMed ID: 24007776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury.
    Rao Y; Zhu W; Liu H; Jia C; Zhao Q; Wang Y
    J Int Med Res; 2013 Apr; 41(2):473-81. PubMed ID: 23569013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury.
    Huang H; Wang H; Chen L; Gu Z; Zhang J; Zhang F; Song Y; Li Y; Tan K; Liu Y; Xi H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Apr; 20(4):434-8. PubMed ID: 16683451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries.
    Chen L; Huang H; Xi H; Zhang F; Liu Y; Chen D; Xiao J
    Cell Transplant; 2014; 23 Suppl 1():S35-44. PubMed ID: 25333925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI.
    Huang H; Chen L; Wang H; Xi H; Gou C; Zhang J; Zhang F; Liu Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Apr; 20(4):439-43. PubMed ID: 16683452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous olfactory ensheathing cell transplantation in human spinal cord injury.
    Féron F; Perry C; Cochrane J; Licina P; Nowitzke A; Urquhart S; Geraghty T; Mackay-Sim A
    Brain; 2005 Dec; 128(Pt 12):2951-60. PubMed ID: 16219671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke.
    Chen L; Xi H; Huang H; Zhang F; Liu Y; Chen D; Xiao J
    Cell Transplant; 2013; 22 Suppl 1():S83-91. PubMed ID: 23992950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transplantation of olfactory ensheathing cells in chronic spinal cord injury: a systematic review and meta-analysis.
    Li L; Adnan H; Xu B; Wang J; Wang C; Li F; Tang K
    Eur Spine J; 2015 May; 24(5):919-30. PubMed ID: 25001890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study.
    Saberi H; Derakhshanrad N; Yekaninejad MS
    Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory ensheathing cells from the nose: clinical application in human spinal cord injuries.
    Mackay-Sim A; St John JA
    Exp Neurol; 2011 May; 229(1):174-80. PubMed ID: 20832402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury.
    Gorrie CA; Hayward I; Cameron N; Kailainathan G; Nandapalan N; Sutharsan R; Wang J; Mackay-Sim A; Waite PM
    Brain Res; 2010 Jun; 1337():8-20. PubMed ID: 20399758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial.
    Mackay-Sim A; Féron F; Cochrane J; Bassingthwaighte L; Bayliss C; Davies W; Fronek P; Gray C; Kerr G; Licina P; Nowitzke A; Perry C; Silburn PA; Urquhart S; Geraghty T
    Brain; 2008 Sep; 131(Pt 9):2376-86. PubMed ID: 18689435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury.
    Wu J; Sun T; Ye C; Yao J; Zhu B; He H
    Cell Transplant; 2012; 21 Suppl 1():S33-7. PubMed ID: 22507678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of COX-2 and iNOS inhibitors alone or in combination with olfactory ensheathing cell grafts after spinal cord injury.
    López-Vales R; García-Alías G; Guzmán-Lenis MS; Forés J; Casas C; Navarro X; Verdú E
    Spine (Phila Pa 1976); 2006 May; 31(10):1100-6. PubMed ID: 16648743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor recovery following olfactory ensheathing cell transplantation in rats with spinal cord injury.
    Tharion G; Indirani K; Durai M; Meenakshi M; Devasahayam SR; Prabhav NR; Solomons C; Bhattacharji S
    Neurol India; 2011; 59(4):566-72. PubMed ID: 21891935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury.
    Lima C; Escada P; Pratas-Vital J; Branco C; Arcangeli CA; Lazzeri G; Maia CA; Capucho C; Hasse-Ferreira A; Peduzzi JD
    Neurorehabil Neural Repair; 2010 Jan; 24(1):10-22. PubMed ID: 19794133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Eskandari G; Mardani A; Rahdari F; Meybodi KT
    Cell Transplant; 2013; 22 Suppl 1():S139-46. PubMed ID: 23992648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary report of multiple cell therapy for patients with multiple system atrophy.
    Xi H; Chen L; Huang H; Zhang F; Liu Y; Chen D; Xiao J
    Cell Transplant; 2013; 22 Suppl 1():S93-9. PubMed ID: 23992875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.